London 12th January 2021: Future Science Group, has chosen The Charlesworth Group for their WeChat Account Management solution.


The Charlesworth Group is the leading sales and marketing agency specialising in providing digital marketing and social media services to STM publishers in China. Charlesworth’s dedicated team is made up of experienced digital marketing specialists, who have expert knowledge of launching and developing new WeChat accounts in the STM space.


Charlesworth will support Future Science Group in creating a dedicated author community within WeChat for their China-based authors. Through WeChat, Future Science Group can engage directly with their stakeholders and potential authors to support their growth in the China market.


The Charlesworth Group CEO Michael Evans commented:

“We are delighted to be working with the Future Science Group for a WeChat Account Management solution. We look forward to helping them grow their author presence in China through building a vibrant stakeholder community on WeChat.”


Future Science Group CEO, Phil Garner commented:

“Social media is increasingly important for both the dissemination and discussion of scientific research. We are looking forward to working with The Charlesworth Group to further extend the reach of our publications through this medium into China, and to growing our author and reader communities through the provision of tailored, local-language scientific and publishing resources.”


About Future Science Group

Founded in 2001, FSG is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. Future Science Group’s portfolio consists of three publishing imprints, Future Science, Future Medicine, Newlands Press, as well as a content development imprint, PharmaPlatforms. In addition to this core publishing business, FSG develops specialist knowledge networks and content hubs, enabling professionals to easily connect and collaborate with their peers in niche scientific fields.

FSG currently publishes 35 peer-reviewed journals as well as 8 knowledge networks and content hubs across a wide range of therapy area and scientific fields. Key journals include BioTechniques, Epigenomics, Future Microbiology and Journal of Comparative Effectiveness Research, alongside sites such as Infectious Diseases Hub, Oncology Central and The Evidence Base.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.


About The Charlesworth Group

With 20 years' experience in China, The Charlesworth Group is recognised globally as China's trusted partner for sales and marketing representation, technical solutions and consultancy for STM publishers internationally and across the Chinese academic market. Charlesworth is also a leading provider of language editing and author services through its Charlesworth Author Services division. The WeChat Gateway was developed by Charlesworth and was nominated at the ALPSP Awards for Innovation in Publishing 2020. It has the ability to integrate publisher platforms and backend systems into WeChat and offers marketing tools and an analytics dashboard to allow publishers to manage all aspects of their WeChat account.

For further information on how Charlesworth supports the global STM publishing community, please visit:
Twitter: @CWGAuthors
LinkedIn: The Charlesworth Group
Facebook: Charlesworth Author Services


For media enquiries, please contact Andrew Smith:

Share with your colleagues